Erratum: Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models (J Clin Invest. (2021) 131: 3 (e144893) DOI: 10.1172/JCI144893)

4Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Following the publication of this article, the authors became aware that an incorrect panel was used for Figure 3B. The correct panel for Figure 3B is below, showing the change in heart rate when mice were challenged with isoproterenol in a murine model of cerebral cavernous malformation treated with vehicle or propranolol. The Figure 3 legend is amended as follows: ∗∗∗P < 0.001, by 2-way repeated-measures ANOVA with a post hoc Tukey's honest significant difference test. The authors have stated that this corrected panel does not affect the results or conclusions of the article. The authors regret the error.

Cite

CITATION STYLE

APA

Li, W., Shenkar, R., Detter, M. R., Moore, T., Benavides, C., Lightle, R., … Awad, I. A. (2021, October 1). Erratum: Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models (J Clin Invest. (2021) 131: 3 (e144893) DOI: 10.1172/JCI144893). Journal of Clinical Investigation. American Society for Clinical Investigation. https://doi.org/10.1172/JCI154909

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free